Rickettsia helvetica spotted fever

Infectious Disease MONDO:0000331 Pathograph 16 Show in embeddings browser Spotted fever rickettsiosis

Rickettsia helvetica spotted fever is a usually mild, often aneruptive, tick-borne spotted-fever-group rickettsiosis caused by the obligately intracellular bacterium Rickettsia helvetica. The organism is associated mainly with Ixodes ricinus in Europe and circulates vertically in ticks; human infection is sparsely reported and often presents as self-limited fever with headache, myalgia, arthralgia, and occasional eschar. Molecular and serologic reports also link R. helvetica to rash-positive bacteremia and rare severe cardiac or neurologic presentations.

Ask OpenScientist

Ask a research question about Rickettsia helvetica spotted fever. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

7
Pathophys.
8
Phenotypes
16
Pathograph
2
Medical Actions
1
Deep Research
🏷

Classifications

Harrison's Part
INFECTIOUS DISEASES
⚙

Pathophysiology

7
Tick-Borne Rickettsia helvetica Inoculation
An infected tick introduces R. helvetica into skin during attachment, seeding a local lesion that can contain rickettsial DNA and, in some patients, necrose into an inoculation eschar.
symbiont entry into host GO:0044409 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves symbiont entry into host (GO:0044409). GO:0044409 is a biological process from the Gene Ontology.
Downstream
Early Monocyte Rickettsia helvetica Survival Tick inoculation can expose early macrophage and monocyte targets to viable rickettsiae.
Inoculation Eschar Bite-site infection can produce a necrotic eschar.
Show evidence (1 reference)
PMID:42520541 SUPPORT Human Clinical
"Rickettsia spp. DNA was detected in capillary blood from both lesions, and sequencing of the PCR amplicons identified R. helvetica"
Lesion-focused PCR after Ixodes attachment detected R. helvetica DNA at bite-associated skin lesions, supporting local inoculation.
Early Monocyte Rickettsia helvetica Survival
In the early post-inoculation phase, monocytes/macrophages can be exposed before vascular endothelial infection is established. In a THP-1 human monocytic model, R. helvetica survived, propagated, and induced TNF-alpha, supporting monocytes as an early host-cell compartment in the pathograph.
monocyte CL:0000576 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves monocyte (CL:0000576). CL:0000576 is a cell type from the Cell Ontology.
biological process involved in interaction with host GO:0051701 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves biological process involved in interaction with host (GO:0051701). GO:0051701 is a biological process from the Gene Ontology. inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Intracytosolic Rickettsia helvetica Niche Monocyte/macrophage survival precedes dissemination to the intracytosolic niches that sustain endothelial infection.
Show evidence (3 references)
PMID:33276122 SUPPORT INDIRECT BACKGROUND In Vitro
"One of the initial targets for rickettsiae after inoculation by ticks is the macrophage/monocyte."
This frames the in-vitro R. helvetica monocyte experiment at the inoculation-to-endothelium step in rickettsial pathogenesis.
PMID:33276122 SUPPORT In Vitro
"R. helvetica survives and propagates in the THP-1 cells."
Human THP-1 monocytic cells supported R. helvetica survival and propagation in vitro.
PMID:33276122 SUPPORT In Vitro
"Infected monocytes induced TNF-α which may be important in host defence against rickettsial infections and promote cell survival and inhibiting cell death by apoptosis."
Infected monocytes initiated a TNF-alpha inflammatory program, supporting the node's link to early inflammatory signaling.
Intracytosolic Rickettsia helvetica Niche
Like pathogenic Rickettsia generally, R. helvetica is modeled as a cytosolic intracellular bacterium; this niche places the organism beyond extracellular-only antibacterial exposure and requires cell-penetrant therapy.
monocyte CL:0000576 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves monocyte (CL:0000576). CL:0000576 is a cell type from the Cell Ontology. vascular endothelial cell CL:0002139 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular endothelial cell, annotated with endothelial cell of vascular tree (CL:0002139). CL:0002139 is a cell type from the Cell Ontology.
biological process involved in interaction with host GO:0051701 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves biological process involved in interaction with host (GO:0051701). GO:0051701 is a biological process from the Gene Ontology.
Downstream
Small-Vessel Rickettsial Vasculitis Systemic rickettsial spread can extend infection to microvascular endothelium.
Rickettsial Ribosomal Translation Cytosolic R. helvetica remains dependent on bacterial ribosomal protein synthesis.
Show evidence (1 reference)
PMID:30148688 SUPPORT INDIRECT REVIEW SYNTHESIS Other
"Residing free in the cytosol of the host cell, they acquire many necessary components via transport mechanisms instead of maintaining genes for synthesizing sugars, lipids, nucleotides, and amino acids."
The rickettsial pathogenesis review supports the free cytosolic niche as the conserved intracellular lifestyle of Rickettsia species.
Small-Vessel Rickettsial Vasculitis
Spotted-fever-group rickettsiae disseminate from the bite site and target microvascular endothelium, producing focal small-vessel vasculitis; in R. helvetica infection this conserved mechanism is kept narrow because most reported human disease is mild and aneruptive.
vascular endothelial cell CL:0002139 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular endothelial cell, annotated with endothelial cell of vascular tree (CL:0002139). CL:0002139 is a cell type from the Cell Ontology.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Fever Endotheliotropic infection and inflammatory signaling drive systemic fever.
Headache Systemic inflammation can present as headache.
Myalgia Systemic inflammation can present as myalgia.
Arthralgia Systemic inflammation can present as arthralgia.
Skin Rash Systemic rickettsial endothelial infection can produce a rash.
Chronic Rickettsial Perimyocarditis Endotheliotropic infection can involve cardiac tissue.
Reported Lymphocytic Meningitis R. helvetica has been implicated in lymphocytic meningitis.
Show evidence (2 references)
PMID:15723687 SUPPORT Human Clinical
"All patients showed a four-fold increase in antibody titer to the spotted fever rickettsia, R. helvetica, and immunohistochemical examination revealed rickettsia-like organisms in the walls of skin capillaries and veins."
R. helvetica-seroconverting human cases had rickettsia-like organisms in skin capillary and venous walls, directly anchoring the endothelial small-vessel lesion.
PMID:30148688 SUPPORT INDIRECT REVIEW SYNTHESIS Other
"The fundamental lesion of rickettsial diseases is vasculitis"
Review synthesis supports small-vessel vasculitis as the shared rickettsial tissue lesion downstream of endothelial infection.
Chronic Rickettsial Perimyocarditis
Rare disseminated R. helvetica infection can involve pericardial, coronary, and myocardial tissue, with chronic interstitial inflammation and endothelium-localized rickettsia-like organisms in reported sudden-cardiac death cases.
vascular endothelial cell CL:0002139 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular endothelial cell, annotated with endothelial cell of vascular tree (CL:0002139). CL:0002139 is a cell type from the Cell Ontology.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Myocarditis Cardiac rickettsial infection can present as myocarditis or perimyocarditis.
Show evidence (1 reference)
PMID:10513711 SUPPORT Human Clinical
"Examination of PCR-positive tissue showed chronic interstitial inflammation and the presence of rickettsia-like organisms predominantly located in the endothelium."
In fatal chronic perimyocarditis cases with R. helvetica DNA, inflamed PCR-positive tissue contained endothelium-localized rickettsia-like organisms.
Reported Lymphocytic Meningitis
R. helvetica has been implicated as a cause of subacute lymphocytic meningitis, defining a rare neurologic branch of disease while leaving the intervening CNS trafficking and inflammatory steps unresolved.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Meningitis Meningeal inflammation manifests clinically as meningitis.
Show evidence (1 reference)
PMID:29996782 SUPPORT BACKGROUND Human Clinical
"Most reports of human exposure have described asymptomatic seroconversion or a mild, self-limiting flu-like illness but it has also been implicated as a cause of subacute lymphocytic meningitis."
The retrospective Danish study summarizes the published neurologic association and places lymphocytic meningitis outside the usual mild flu-like presentation.
Rickettsial Ribosomal Translation
R. helvetica requires bacterial 70S ribosomal translation to synthesize proteins; doxycycline reaches intracellular rickettsiae and blocks the 30S ribosomal subunit.
Translation GO:0006412 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves Translation (GO:0006412). GO:0006412 is a biological process from the Gene Ontology. response to antibiotic GO:0046677 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves response to antibiotic (GO:0046677). GO:0046677 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:24336183 SUPPORT INDIRECT REVIEW SYNTHESIS Other
"The ribosome is one of the main antibiotic targets in the bacterial cell."
Review evidence establishes the bacterial ribosome as the conserved target of tetracycline-class therapy; the R. helvetica-specific treatment evidence below establishes doxycycline responsiveness in human disease.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Rickettsia helvetica spotted fever Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

8
Cardiovascular 1
Myocarditis HP:0012819 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Myocarditis (HP:0012819). HP:0012819 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10513711 SUPPORT Human Clinical
"We studied two young Swedish men who died of sudden cardiac failure during exercise, and who showed signs of perimyocarditis similar to those described in rickettsial disease."
The case report ties R. helvetica infection to fatal chronic perimyocarditis in two young men.
Immune 2
Skin Rash HP:0000988 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Skin rash (HP:0000988). HP:0000988 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18649945 SUPPORT Human Clinical
"In the present case, however, where the presence of R. helvetica in the blood was verified by PCR together with serologic evidence of infection, the patient presented a different clinical picture with acute febrile illness, rash and long-lasting myasthenia."
A bacteremic PCR- and serology-supported case shows that R. helvetica can present with rash despite the usual aneruptive pattern.
Meningitis HP:0001287 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Meningitis (HP:0001287). HP:0001287 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:29996782 SUPPORT BACKGROUND Human Clinical
"Most reports of human exposure have described asymptomatic seroconversion or a mild, self-limiting flu-like illness but it has also been implicated as a cause of subacute lymphocytic meningitis."
The Danish study cites subacute lymphocytic meningitis as a published severe neurologic presentation of R. helvetica infection.
Integument 1
Inoculation Eschar HP:6000793 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Eschar (HP:6000793). HP:6000793 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14766859 SUPPORT Human Clinical
"Clinical symptoms included fever, headache, and arthralgia in all patients, myalgia in four, and an inoculation eschar in one but no cutaneous rash."
The series recorded an inoculation eschar in only one patient, supporting eschar as possible rather than typical for R. helvetica infection.
Metabolism 1
Fever VERY_FREQUENT HP:0001945 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fever (HP:0001945). HP:0001945 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14766859 SUPPORT Human Clinical
"Clinical symptoms included fever, headache, and arthralgia in all patients, myalgia in four, and an inoculation eschar in one but no cutaneous rash."
The eight-patient serologic case series identifies fever as part of the dominant mild aneruptive presentation.
Nervous System 1
Headache VERY_FREQUENT HP:0002315 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Headache (HP:0002315). HP:0002315 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14766859 SUPPORT Human Clinical
"Clinical symptoms included fever, headache, and arthralgia in all patients, myalgia in four, and an inoculation eschar in one but no cutaneous rash."
The serologic case series places headache in the dominant R. helvetica symptom complex.
Constitutional 2
Myalgia FREQUENT HP:0003326 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Myalgia (HP:0003326). HP:0003326 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14766859 SUPPORT Human Clinical
"Clinical symptoms included fever, headache, and arthralgia in all patients, myalgia in four, and an inoculation eschar in one but no cutaneous rash."
Four of the European serologically supported patients had myalgia.
Arthralgia HP:0002829 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Arthralgia (HP:0002829). HP:0002829 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14766859 SUPPORT Human Clinical
"Clinical symptoms included fever, headache, and arthralgia in all patients, myalgia in four, and an inoculation eschar in one but no cutaneous rash."
Arthralgia was reported in the European serologically supported R. helvetica cases.
💊

Medical Actions

2
Empiric doxycycline for spotted-fever-group rickettsiosis
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: doxycycline CHEBI:50845 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses doxycycline (CHEBI:50845). CHEBI:50845 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Suspected R. helvetica disease is treated with doxycycline, a cell-penetrant tetracycline that reaches the rickettsial cytosolic niche and inhibits bacterial 30S ribosomal translation; post-bite prophylactic doxycycline is not recommended for asymptomatic tick exposure.
Mechanism Target:
INHIBITS Rickettsial Ribosomal Translation — Doxycycline inhibits R. helvetica by binding the bacterial 30S ribosomal subunit and arresting protein synthesis.
BYPASSES Intracytosolic Rickettsia helvetica Niche — Intracellular accumulation lets doxycycline reach the cytosolic rickettsial niche.
Show evidence (3 references)
PMID:42520541 SUPPORT Human Clinical
"Clinical signs resolved after doxycycline."
The two molecularly confirmed Serbian human cases had clinical resolution after doxycycline.
PMID:27172113 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Doxycycline is the drug of choice for treatment of all tickborne rickettsial diseases in patients of all ages, including children aged <8 years, and should be initiated immediately in persons with signs and symptoms suggestive of rickettsial disease"
CDC guidance for tickborne rickettsial diseases supports doxycycline as the empiric treatment for suspected rickettsioses while diagnostic testing is pending.
PMID:27172113 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Prophylactic use of doxycycline after a tick bite is not recommended for the prevention of tickborne rickettsial diseases."
Supports avoiding post-exposure antibiotic prophylaxis after an asymptomatic tick bite.
Tick-bite prevention counseling
Category: Counseling / Informational Action: tick-bite prevention counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is tick-bite prevention counseling, annotated with Behavioral Counseling (NCIT:C181743). NCIT:C181743 is a clinical intervention from the NCI Thesaurus. Ontology label: Behavioral Counseling NCIT:C181743
Platform: Behavioral / lifestyle
Primary prevention interrupts the tick-inoculation trigger through avoidance of tick-infested habitats when possible, topical DEET on exposed skin, permethrin-treated clothing, protective clothing, regular tick checks, and prompt mechanical removal of attached ticks.
Show evidence (2 references)
PMID:27172113 SUPPORT Human Clinical
"No vaccine is licensed for the prevention of tickborne rickettsial diseases in the United States. Avoiding tick bites and promptly removing attached ticks remain the best disease prevention strategies."
Establishes bite avoidance and tick removal as the primary preventive approach for tickborne rickettsioses.
PMID:17338947 SUPPORT INDIRECT REVIEW SYNTHESIS Other
"The best method to avoid tick bites is twofold: application of a topical deet (N,N-diethyl-m-toluamide) repellent to exposed skin, and treatment of clothing with permethrin."
Review guidance names topical DEET and permethrin-treated clothing as the main personal-protection measures against tick bites.
🔬

Diagnosis

2
Paired-serum indirect immunofluorescence antibody assay
Paired acute and convalescent IgG IFA can retrospectively confirm spotted fever group rickettsiosis when the titer rises at least fourfold. Because serology cross-reacts within the spotted fever group, species-level assignment of R. helvetica needs an R. helvetica-focused antigen strategy, Western blot, cross-adsorption, or molecular confirmation.
serologic testing NCIT:C25294 NCI Thesaurus (NCIT)
Results: A fourfold rise in paired R. helvetica IgG titers supports recent infection.
Show evidence (3 references)
PMID:15723687 SUPPORT Human Clinical
"All patients showed a four-fold increase in antibody titer to the spotted fever rickettsia, R. helvetica"
The Swedish clinical study documents paired-serum seroconversion to R. helvetica in three tick-bite-associated cases.
PMID:27172113 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"A diagnosis of tickborne rickettsial disease is confirmed with a fourfold or greater increase in antibody titer in samples collected at appropriately timed intervals in patients with a clinically compatible acute illness"
CDC tickborne-rickettsiosis guidance defines the fourfold-rise standard that also applies to spotted-fever-group R. helvetica infection.
PMID:27172113 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Cross-reactive immune responses to rickettsial antigens result in antibodies that are typically group-specific, although perhaps not species-specific, for tickborne rickettsial pathogens"
CDC guidance explains why a spotted-fever-group serologic response alone cannot reliably assign the infection to R. helvetica.
Lesion or tissue rickettsial PCR with sequencing
PCR can amplify rickettsial DNA from lesion capillary blood, skin lesions, or involved tissues and sequencing then assigns the infecting species. A negative whole-blood PCR does not exclude a localized R. helvetica infection when the lesion itself remains PCR-positive.
PCR-based molecular diagnosis NCIT:C25294 NCI Thesaurus (NCIT)
Results: Rickettsial DNA amplified from a lesion or tissue and sequenced as R. helvetica.
Show evidence (3 references)
PMID:42520541 SUPPORT Human Clinical
"Rickettsia spp. DNA was detected in capillary blood from both lesions, and sequencing of the PCR amplicons identified R. helvetica, while whole blood was PCR-negative and serology did not show reproducible seroconversion."
Lesion capillary blood confirmed R. helvetica by PCR and sequencing even when the same patient's whole blood and serology were uninformative.
PMID:10513711 SUPPORT Human Clinical
"By use of a semi-nested PCR, with primers specific for the 16S rRNA and 17-kDa outer-membrane-protein genes, and sequence analysis of the amplified products, genetic material from R. helvetica was detected in the pericardium and in a lymph node from the pulmonary hilum in case 1, and in a..."
The cardiac case report used 16S and 17-kDa PCR followed by sequencing to localize R. helvetica DNA to inflamed cardiac and lymph-node tissue.
PMID:27172113 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"For eschar-producing tickborne rickettsial diseases, including R. parkeri, Rickettsia species 364D, and R. africae, an eschar biopsy, a swab of eschar exudate, or scab material from the eschar surface can provide suitable specimens for molecular confirmation of SFG rickettsial DNA"
The CDC report supports skin lesion material as a high-yield specimen type for spotted-fever-group rickettsial PCR, indirectly supporting the same sampling strategy when an R. helvetica bite site or eschar is present.
🦠

Infectious Agent

1
Rickettsia helvetica
Obligate intracellular spotted-fever-group rickettsial bacterium associated with human febrile illness after exposure to infected Ixodes ticks.
Rickettsia helvetica NCBITaxon:35789 NCBI Taxonomy (NCBITaxon)
Show evidence (1 reference)
PMID:42520541 SUPPORT Human Clinical
"Rickettsia helvetica is a spotted fever group rickettsia associated mainly with Ixodes ricinus and increasingly detected in European ticks."
Molecularly confirmed Serbian human cases identify R. helvetica as a spotted-fever-group Rickettsia linked to human tick-bite illness.
↔️

Transmission

1
Ixodes-associated tick bite transmission
Humans are exposed when infected Ixodes ticks feed and inoculate R. helvetica from the enzootic tick reservoir; I. ricinus maintains stable R. helvetica infection in Europe through efficient transovarial transmission, while vertebrate hosts disperse infected ticks and organisms.
Show evidence (2 references)
PMID:19732416 SUPPORT Other
"The simplest explanation for the comparable prevalence of R. helvetica between the defined tick stages is, that R. helvetica is vertically transmitted through the next generation with high efficiency."
A longitudinal Dutch tick survey found R. helvetica in I. ricinus larvae, nymphs, and adults at comparable prevalence, supporting I. ricinus as the reservoir tick.
PMID:42520541 SUPPORT Human Clinical
"We describe two tick-bite-associated human cases in Serbia in May 2025."
The Serbian molecular detections establish that human cases follow tick attachment.
{ }

Source YAML

click to show 
name: Rickettsia helvetica spotted fever
creation_date: "2026-09-28T09:11:00Z"
category: Infectious Disease
description: >-
  Rickettsia helvetica spotted fever is a usually mild, often aneruptive,
  tick-borne spotted-fever-group rickettsiosis caused by the obligately
  intracellular bacterium Rickettsia helvetica. The organism is associated
  mainly with Ixodes ricinus in Europe and circulates vertically in ticks;
  human infection is sparsely reported and often presents as self-limited fever
  with headache, myalgia, arthralgia, and occasional eschar. Molecular and
  serologic reports also link R. helvetica to rash-positive bacteremia and rare
  severe cardiac or neurologic presentations.
disease_term:
  preferred_term: Rickettsia helvetica spotted fever
  term:
    id: MONDO:0000331
    label: Rickettsia helvetica spotted fever
parents:
- Spotted fever rickettsiosis
synonyms:
- Rickettsia helvetica infection
- Rickettsia helvetica aneruptive fever
classifications:
  harrisons_chapter:
  - classification_value: INFECTIOUS_DISEASES
    evidence:
    - reference: PMID:14766859
      reference_title: >-
        Aneruptive fever associated with antibodies to Rickettsia helvetica in
        Europe and Thailand.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We report that eight patients from France, Italy, and Thailand had
        serological evidence of Rickettsia helvetica infection.
      explanation: >-
        The case series frames R. helvetica spotted fever as an acute bacterial
        rickettsial infection, placing it in Harrison's Infectious Diseases
        Part.

infectious_agent:
- name: Rickettsia helvetica
  infectious_agent_term:
    preferred_term: Rickettsia helvetica
    term:
      id: NCBITaxon:35789
      label: Rickettsia helvetica
  description: >-
    Obligate intracellular spotted-fever-group rickettsial bacterium associated
    with human febrile illness after exposure to infected Ixodes ticks.
  evidence:
  - reference: PMID:42520541
    reference_title: >-
      Molecular detection of Rickettsia helvetica in lesion and blood samples
      after tick bites in Serbia: two cases with One Health implications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rickettsia helvetica is a spotted fever group rickettsia associated
      mainly with Ixodes ricinus and increasingly detected in European ticks.
    explanation: >-
      Molecularly confirmed Serbian human cases identify R. helvetica as a
      spotted-fever-group Rickettsia linked to human tick-bite illness.

transmission:
- name: Ixodes-associated tick bite transmission
  description: >-
    Humans are exposed when infected Ixodes ticks feed and inoculate R.
    helvetica from the enzootic tick reservoir; I. ricinus maintains stable
    R. helvetica infection in Europe through efficient transovarial
    transmission, while vertebrate hosts disperse infected ticks and organisms.
  evidence:
  - reference: PMID:19732416
    reference_title: >-
      Ixodes ricinus ticks are reservoir hosts for Rickettsia helvetica and
      potentially carry flea-borne Rickettsia species.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The simplest explanation for the comparable prevalence of R. helvetica
      between the defined tick stages is, that R. helvetica is vertically
      transmitted through the next generation with high efficiency.
    explanation: >-
      A longitudinal Dutch tick survey found R. helvetica in I. ricinus larvae,
      nymphs, and adults at comparable prevalence, supporting I. ricinus as the
      reservoir tick.
  - reference: PMID:42520541
    reference_title: >-
      Molecular detection of Rickettsia helvetica in lesion and blood samples
      after tick bites in Serbia: two cases with One Health implications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe two tick-bite-associated human cases in Serbia in May 2025.
    explanation: >-
      The Serbian molecular detections establish that human cases follow tick
      attachment.

diagnosis:
- name: Paired-serum indirect immunofluorescence antibody assay
  description: >-
    Paired acute and convalescent IgG IFA can retrospectively confirm spotted
    fever group rickettsiosis when the titer rises at least fourfold. Because
    serology cross-reacts within the spotted fever group, species-level
    assignment of R. helvetica needs an R. helvetica-focused antigen strategy,
    Western blot, cross-adsorption, or molecular confirmation.
  diagnosis_term:
    preferred_term: serologic testing
    term:
      id: NCIT:C25294
      label: Laboratory Procedure
  results: A fourfold rise in paired R. helvetica IgG titers supports recent infection.
  evidence:
  - reference: PMID:15723687
    reference_title: >-
      Evidence of Rickettsia spp. infection in Sweden: a clinical,
      ultrastructural and serological study.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients showed a four-fold increase in antibody titer to the spotted
      fever rickettsia, R. helvetica
    explanation: >-
      The Swedish clinical study documents paired-serum seroconversion to
      R. helvetica in three tick-bite-associated cases.
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A diagnosis of tickborne rickettsial disease is confirmed with a
      fourfold or greater increase in antibody titer in samples collected at
      appropriately timed intervals in patients with a clinically compatible
      acute illness
    explanation: >-
      CDC tickborne-rickettsiosis guidance defines the fourfold-rise standard
      that also applies to spotted-fever-group R. helvetica infection.
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cross-reactive immune responses to rickettsial antigens result in
      antibodies that are typically group-specific, although perhaps not
      species-specific, for tickborne rickettsial pathogens
    explanation: >-
      CDC guidance explains why a spotted-fever-group serologic response alone
      cannot reliably assign the infection to R. helvetica.

- name: Lesion or tissue rickettsial PCR with sequencing
  description: >-
    PCR can amplify rickettsial DNA from lesion capillary blood, skin lesions,
    or involved tissues and sequencing then assigns the infecting species. A
    negative whole-blood PCR does not exclude a localized R. helvetica
    infection when the lesion itself remains PCR-positive.
  diagnosis_term:
    preferred_term: PCR-based molecular diagnosis
    term:
      id: NCIT:C25294
      label: Laboratory Procedure
  results: Rickettsial DNA amplified from a lesion or tissue and sequenced as R. helvetica.
  evidence:
  - reference: PMID:42520541
    reference_title: >-
      Molecular detection of Rickettsia helvetica in lesion and blood samples
      after tick bites in Serbia: two cases with One Health implications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rickettsia spp. DNA was detected in capillary blood from both lesions,
      and sequencing of the PCR amplicons identified R. helvetica, while whole
      blood was PCR-negative and serology did not show reproducible
      seroconversion.
    explanation: >-
      Lesion capillary blood confirmed R. helvetica by PCR and sequencing even
      when the same patient's whole blood and serology were uninformative.
  - reference: PMID:10513711
    reference_title: >-
      Association of Rickettsia helvetica with chronic perimyocarditis in
      sudden cardiac death.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      By use of a semi-nested PCR, with primers specific for the 16S rRNA and
      17-kDa outer-membrane-protein genes, and sequence analysis of the
      amplified products, genetic material from R. helvetica was detected in
      the pericardium and in a lymph node from the pulmonary hilum in case 1,
      and in a coronary artery and the heart muscle in case 2.
    explanation: >-
      The cardiac case report used 16S and 17-kDa PCR followed by sequencing to
      localize R. helvetica DNA to inflamed cardiac and lymph-node tissue.
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      For eschar-producing tickborne rickettsial diseases, including R.
      parkeri, Rickettsia species 364D, and R. africae, an eschar biopsy, a
      swab of eschar exudate, or scab material from the eschar surface can
      provide suitable specimens for molecular confirmation of SFG rickettsial
      DNA
    explanation: >-
      The CDC report supports skin lesion material as a high-yield specimen
      type for spotted-fever-group rickettsial PCR, indirectly supporting the
      same sampling strategy when an R. helvetica bite site or eschar is
      present.

pathophysiology:
- name: Tick-Borne Rickettsia helvetica Inoculation
  role: trigger
  biological_scale: ORGANISM
  description: >-
    An infected tick introduces R. helvetica into skin during attachment,
    seeding a local lesion that can contain rickettsial DNA and, in some
    patients, necrose into an inoculation eschar.
  biological_processes:
  - preferred_term: symbiont entry into host
    term:
      id: GO:0044409
      label: symbiont entry into host
  downstream:
  - target: Early Monocyte Rickettsia helvetica Survival
    causal_link_type: DIRECT
    description: >-
      Tick inoculation can expose early macrophage and monocyte targets to
      viable rickettsiae.
  - target: Inoculation Eschar
    causal_link_type: DIRECT
    description: Bite-site infection can produce a necrotic eschar.
  evidence:
  - reference: PMID:42520541
    reference_title: >-
      Molecular detection of Rickettsia helvetica in lesion and blood samples
      after tick bites in Serbia: two cases with One Health implications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rickettsia spp. DNA was detected in capillary blood from both lesions,
      and sequencing of the PCR amplicons identified R. helvetica
    explanation: >-
      Lesion-focused PCR after Ixodes attachment detected R. helvetica DNA at
      bite-associated skin lesions, supporting local inoculation.

- name: Early Monocyte Rickettsia helvetica Survival
  role: intracellular_persistence
  biological_scale: CELLULAR
  description: >-
    In the early post-inoculation phase, monocytes/macrophages can be exposed
    before vascular endothelial infection is established. In a THP-1 human
    monocytic model, R. helvetica survived, propagated, and induced TNF-alpha,
    supporting monocytes as an early host-cell compartment in the pathograph.
  cell_types:
  - preferred_term: monocyte
    term:
      id: CL:0000576
      label: monocyte
  biological_processes:
  - preferred_term: biological process involved in interaction with host
    term:
      id: GO:0051701
      label: biological process involved in interaction with host
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Intracytosolic Rickettsia helvetica Niche
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Monocyte/macrophage survival precedes dissemination to the
      intracytosolic niches that sustain endothelial infection.
  evidence:
  - reference: PMID:33276122
    reference_title: >-
      Characteristics of in vitro infection of human monocytes, by Rickettsia
      helvetica.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: BACKGROUND
    evidence_source: IN_VITRO
    snippet: >-
      One of the initial targets for rickettsiae after inoculation by ticks is
      the macrophage/monocyte.
    explanation: >-
      This frames the in-vitro R. helvetica monocyte experiment at the
      inoculation-to-endothelium step in rickettsial pathogenesis.
  - reference: PMID:33276122
    reference_title: >-
      Characteristics of in vitro infection of human monocytes, by Rickettsia
      helvetica.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: R. helvetica survives and propagates in the THP-1 cells.
    explanation: >-
      Human THP-1 monocytic cells supported R. helvetica survival and
      propagation in vitro.
  - reference: PMID:33276122
    reference_title: >-
      Characteristics of in vitro infection of human monocytes, by Rickettsia
      helvetica.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Infected monocytes induced TNF-α which may be important in host defence
      against rickettsial infections and promote cell survival and inhibiting
      cell death by apoptosis.
    explanation: >-
      Infected monocytes initiated a TNF-alpha inflammatory program, supporting
      the node's link to early inflammatory signaling.

- name: Intracytosolic Rickettsia helvetica Niche
  role: intrinsic_resistance
  conforms_to: >-
    intracellular_pathogen_persistence#Intracellular Niche and Beta-Lactam
    Exclusion
  biological_scale: CELLULAR
  description: >-
    Like pathogenic Rickettsia generally, R. helvetica is modeled as a
    cytosolic intracellular bacterium; this niche places the organism beyond
    extracellular-only antibacterial exposure and requires cell-penetrant
    therapy.
  cell_types:
  - preferred_term: monocyte
    term:
      id: CL:0000576
      label: monocyte
  - preferred_term: vascular endothelial cell
    term:
      id: CL:0002139
      label: endothelial cell of vascular tree
  biological_processes:
  - preferred_term: biological process involved in interaction with host
    term:
      id: GO:0051701
      label: biological process involved in interaction with host
  downstream:
  - target: Small-Vessel Rickettsial Vasculitis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Systemic rickettsial spread can extend infection to microvascular endothelium.
  - target: Rickettsial Ribosomal Translation
    causal_link_type: DIRECT
    description: Cytosolic R. helvetica remains dependent on bacterial ribosomal protein synthesis.
  evidence:
  - reference: PMID:30148688
    reference_title: >-
      Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms
      of an Endotheliotropic Infection.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Residing free in the cytosol of the host cell, they acquire many
      necessary components via transport mechanisms instead of maintaining
      genes for synthesizing sugars, lipids, nucleotides, and amino acids.
    explanation: >-
      The rickettsial pathogenesis review supports the free cytosolic niche as
      the conserved intracellular lifestyle of Rickettsia species.

- name: Small-Vessel Rickettsial Vasculitis
  role: vascular_response
  biological_scale: TISSUE
  description: >-
    Spotted-fever-group rickettsiae disseminate from the bite site and target
    microvascular endothelium, producing focal small-vessel vasculitis; in
    R. helvetica infection this conserved mechanism is kept narrow because most
    reported human disease is mild and aneruptive.
  cell_types:
  - preferred_term: vascular endothelial cell
    term:
      id: CL:0002139
      label: endothelial cell of vascular tree
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Fever
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Endotheliotropic infection and inflammatory signaling drive systemic fever.
  - target: Headache
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Systemic inflammation can present as headache.
  - target: Myalgia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Systemic inflammation can present as myalgia.
  - target: Arthralgia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Systemic inflammation can present as arthralgia.
  - target: Skin Rash
    causal_link_type: DIRECT
    description: Systemic rickettsial endothelial infection can produce a rash.
  - target: Chronic Rickettsial Perimyocarditis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Endotheliotropic infection can involve cardiac tissue.
  - target: Reported Lymphocytic Meningitis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: R. helvetica has been implicated in lymphocytic meningitis.
  evidence:
  - reference: PMID:15723687
    reference_title: >-
      Evidence of Rickettsia spp. infection in Sweden: a clinical,
      ultrastructural and serological study.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients showed a four-fold increase in antibody titer to the spotted
      fever rickettsia, R. helvetica, and immunohistochemical examination
      revealed rickettsia-like organisms in the walls of skin capillaries and
      veins.
    explanation: >-
      R. helvetica-seroconverting human cases had rickettsia-like organisms in
      skin capillary and venous walls, directly anchoring the endothelial
      small-vessel lesion.
  - reference: PMID:30148688
    reference_title: >-
      Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms
      of an Endotheliotropic Infection.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      The fundamental lesion of rickettsial diseases is vasculitis
    explanation: >-
      Review synthesis supports small-vessel vasculitis as the shared
      rickettsial tissue lesion downstream of endothelial infection.

- name: Chronic Rickettsial Perimyocarditis
  role: organ_injury
  biological_scale: TISSUE
  description: >-
    Rare disseminated R. helvetica infection can involve pericardial, coronary,
    and myocardial tissue, with chronic interstitial inflammation and
    endothelium-localized rickettsia-like organisms in reported sudden-cardiac
    death cases.
  cell_types:
  - preferred_term: vascular endothelial cell
    term:
      id: CL:0002139
      label: endothelial cell of vascular tree
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Myocarditis
    causal_link_type: DIRECT
    description: Cardiac rickettsial infection can present as myocarditis or perimyocarditis.
  evidence:
  - reference: PMID:10513711
    reference_title: >-
      Association of Rickettsia helvetica with chronic perimyocarditis in
      sudden cardiac death.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Examination of PCR-positive tissue showed chronic interstitial
      inflammation and the presence of rickettsia-like organisms predominantly
      located in the endothelium.
    explanation: >-
      In fatal chronic perimyocarditis cases with R. helvetica DNA, inflamed
      PCR-positive tissue contained endothelium-localized rickettsia-like
      organisms.

- name: Reported Lymphocytic Meningitis
  role: neurologic_complication
  biological_scale: TISSUE
  description: >-
    R. helvetica has been implicated as a cause of subacute lymphocytic
    meningitis, defining a rare neurologic branch of disease while leaving the
    intervening CNS trafficking and inflammatory steps unresolved.
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Meningitis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Meningeal inflammation manifests clinically as meningitis.
  evidence:
  - reference: PMID:29996782
    reference_title: >-
      Evidence of rickettsiae in Danish patients tested for Lyme
      neuroborreliosis: a retrospective study of archival samples.
    supports: SUPPORT
    quote_role: BACKGROUND
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most reports of human exposure have described asymptomatic seroconversion
      or a mild, self-limiting flu-like illness but it has also been implicated
      as a cause of subacute lymphocytic meningitis.
    explanation: >-
      The retrospective Danish study summarizes the published neurologic
      association and places lymphocytic meningitis outside the usual mild
      flu-like presentation.

- name: Rickettsial Ribosomal Translation
  role: therapeutic_vulnerability
  conforms_to: >-
    bacterial_protein_synthesis_inhibition#Bacterial mRNA Translation by the
    Ribosome
  biological_scale: MOLECULAR
  description: >-
    R. helvetica requires bacterial 70S ribosomal translation to synthesize
    proteins; doxycycline reaches intracellular rickettsiae and blocks the 30S
    ribosomal subunit.
  biological_processes:
  - preferred_term: Translation
    term:
      id: GO:0006412
      label: translation
  - preferred_term: response to antibiotic
    term:
      id: GO:0046677
      label: response to antibiotic
  evidence:
  - reference: PMID:24336183
    reference_title: Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The ribosome is one of the main antibiotic targets in the bacterial cell.
    explanation: >-
      Review evidence establishes the bacterial ribosome as the conserved target
      of tetracycline-class therapy; the R. helvetica-specific treatment
      evidence below establishes doxycycline responsiveness in human disease.

phenotypes:
- name: Fever
  category: Constitutional
  frequency: VERY_FREQUENT
  description: Fever is the cardinal systemic manifestation of R. helvetica infection.
  phenotype_term:
    preferred_term: Fever
    term:
      id: HP:0001945
      label: Fever
  evidence:
  - reference: PMID:14766859
    reference_title: >-
      Aneruptive fever associated with antibodies to Rickettsia helvetica in
      Europe and Thailand.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms included fever, headache, and arthralgia in all
      patients, myalgia in four, and an inoculation eschar in one but no
      cutaneous rash.
    explanation: >-
      The eight-patient serologic case series identifies fever as part of the
      dominant mild aneruptive presentation.

- name: Headache
  category: Neurologic
  frequency: VERY_FREQUENT
  description: Headache accompanies the acute febrile syndrome.
  phenotype_term:
    preferred_term: Headache
    term:
      id: HP:0002315
      label: Headache
  evidence:
  - reference: PMID:14766859
    reference_title: >-
      Aneruptive fever associated with antibodies to Rickettsia helvetica in
      Europe and Thailand.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms included fever, headache, and arthralgia in all
      patients, myalgia in four, and an inoculation eschar in one but no
      cutaneous rash.
    explanation: >-
      The serologic case series places headache in the dominant R. helvetica
      symptom complex.

- name: Myalgia
  category: Musculoskeletal
  frequency: FREQUENT
  description: Myalgia is part of the nonspecific flu-like syndrome.
  phenotype_term:
    preferred_term: Myalgia
    term:
      id: HP:0003326
      label: Myalgia
  evidence:
  - reference: PMID:14766859
    reference_title: >-
      Aneruptive fever associated with antibodies to Rickettsia helvetica in
      Europe and Thailand.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms included fever, headache, and arthralgia in all
      patients, myalgia in four, and an inoculation eschar in one but no
      cutaneous rash.
    explanation: >-
      Four of the European serologically supported patients had myalgia.

- name: Arthralgia
  category: Musculoskeletal
  description: Arthralgia can accompany the acute R. helvetica febrile illness.
  phenotype_term:
    preferred_term: Arthralgia
    term:
      id: HP:0002829
      label: Arthralgia
  evidence:
  - reference: PMID:14766859
    reference_title: >-
      Aneruptive fever associated with antibodies to Rickettsia helvetica in
      Europe and Thailand.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms included fever, headache, and arthralgia in all
      patients, myalgia in four, and an inoculation eschar in one but no
      cutaneous rash.
    explanation: >-
      Arthralgia was reported in the European serologically supported
      R. helvetica cases.

- name: Inoculation Eschar
  category: Dermatologic
  description: >-
    A necrotic eschar can occur at the infected tick attachment site, although
    it was uncommon in the small published case series.
  phenotype_term:
    preferred_term: Eschar
    term:
      id: HP:6000793
      label: Eschar
  evidence:
  - reference: PMID:14766859
    reference_title: >-
      Aneruptive fever associated with antibodies to Rickettsia helvetica in
      Europe and Thailand.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms included fever, headache, and arthralgia in all
      patients, myalgia in four, and an inoculation eschar in one but no
      cutaneous rash.
    explanation: >-
      The series recorded an inoculation eschar in only one patient, supporting
      eschar as possible rather than typical for R. helvetica infection.

- name: Skin Rash
  category: Dermatologic
  description: >-
    R. helvetica is often described as aneruptive, but PCR- and
    serology-supported bacteremic disease can include rash.
  phenotype_term:
    preferred_term: Skin rash
    term:
      id: HP:0000988
      label: Skin rash
  evidence:
  - reference: PMID:18649945
    reference_title: >-
      Septicaemia with Rickettsia helvetica in a patient with acute febrile
      illness, rash and myasthenia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the present case, however, where the presence of R. helvetica in the
      blood was verified by PCR together with serologic evidence of infection,
      the patient presented a different clinical picture with acute febrile
      illness, rash and long-lasting myasthenia.
    explanation: >-
      A bacteremic PCR- and serology-supported case shows that R. helvetica can
      present with rash despite the usual aneruptive pattern.

- name: Myocarditis
  category: Cardiovascular
  description: >-
    Chronic perimyocarditis with R. helvetica DNA in cardiac tissue has been
    reported in sudden cardiac death.
  phenotype_term:
    preferred_term: Myocarditis
    term:
      id: HP:0012819
      label: Myocarditis
  evidence:
  - reference: PMID:10513711
    reference_title: >-
      Association of Rickettsia helvetica with chronic perimyocarditis in
      sudden cardiac death.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We studied two young Swedish men who died of sudden cardiac failure
      during exercise, and who showed signs of perimyocarditis similar to those
      described in rickettsial disease.
    explanation: >-
      The case report ties R. helvetica infection to fatal chronic
      perimyocarditis in two young men.

- name: Meningitis
  category: Neurologic
  description: R. helvetica has been implicated in subacute lymphocytic meningitis.
  phenotype_term:
    preferred_term: Meningitis
    term:
      id: HP:0001287
      label: Meningitis
  evidence:
  - reference: PMID:29996782
    reference_title: >-
      Evidence of rickettsiae in Danish patients tested for Lyme
      neuroborreliosis: a retrospective study of archival samples.
    supports: SUPPORT
    quote_role: BACKGROUND
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most reports of human exposure have described asymptomatic seroconversion
      or a mild, self-limiting flu-like illness but it has also been implicated
      as a cause of subacute lymphocytic meningitis.
    explanation: >-
      The Danish study cites subacute lymphocytic meningitis as a published
      severe neurologic presentation of R. helvetica infection.

treatments:
- name: Empiric doxycycline for spotted-fever-group rickettsiosis
  therapeutic_modality: SMALL_MOLECULE
  description: >-
    Suspected R. helvetica disease is treated with doxycycline, a
    cell-penetrant tetracycline that reaches the rickettsial cytosolic niche
    and inhibits bacterial 30S ribosomal translation; post-bite prophylactic
    doxycycline is not recommended for asymptomatic tick exposure.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: doxycycline
      term:
        id: CHEBI:50845
        label: doxycycline
  target_mechanisms:
  - target: Rickettsial Ribosomal Translation
    treatment_effect: INHIBITS
    description: >-
      Doxycycline inhibits R. helvetica by binding the bacterial 30S ribosomal
      subunit and arresting protein synthesis.
  - target: Intracytosolic Rickettsia helvetica Niche
    treatment_effect: BYPASSES
    description: >-
      Intracellular accumulation lets doxycycline reach the cytosolic rickettsial
      niche.
  evidence:
  - reference: PMID:42520541
    reference_title: >-
      Molecular detection of Rickettsia helvetica in lesion and blood samples
      after tick bites in Serbia: two cases with One Health implications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Clinical signs resolved after doxycycline.
    explanation: >-
      The two molecularly confirmed Serbian human cases had clinical resolution
      after doxycycline.
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Doxycycline is the drug of choice for treatment of all tickborne
      rickettsial diseases in patients of all ages, including children aged <8
      years, and should be initiated immediately in persons with signs and
      symptoms suggestive of rickettsial disease
    explanation: >-
      CDC guidance for tickborne rickettsial diseases supports doxycycline as
      the empiric treatment for suspected rickettsioses while diagnostic testing
      is pending.
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Prophylactic use of doxycycline after a tick bite is not recommended for
      the prevention of tickborne rickettsial diseases.
    explanation: >-
      Supports avoiding post-exposure antibiotic prophylaxis after an
      asymptomatic tick bite.

- name: Tick-bite prevention counseling
  action_category: COUNSELING_INFORMATIONAL
  therapeutic_modality: BEHAVIORAL
  description: >-
    Primary prevention interrupts the tick-inoculation trigger through avoidance
    of tick-infested habitats when possible, topical DEET on exposed skin,
    permethrin-treated clothing, protective clothing, regular tick checks, and
    prompt mechanical removal of attached ticks.
  treatment_term:
    preferred_term: tick-bite prevention counseling
    term:
      id: NCIT:C181743
      label: Behavioral Counseling
  evidence:
  - reference: PMID:27172113
    reference_title: >-
      Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky
      Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses,
      Ehrlichioses, and Anaplasmosis - United States.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      No vaccine is licensed for the prevention of tickborne rickettsial
      diseases in the United States. Avoiding tick bites and promptly removing
      attached ticks remain the best disease prevention strategies.
    explanation: >-
      Establishes bite avoidance and tick removal as the primary preventive
      approach for tickborne rickettsioses.
  - reference: PMID:17338947
    reference_title: Rickettsial and other tick-borne infections.
    supports: SUPPORT
    directness: INDIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: OTHER
    snippet: >-
      The best method to avoid tick bites is twofold: application of a topical
      deet (N,N-diethyl-m-toluamide) repellent to exposed skin, and treatment
      of clothing with permethrin.
    explanation: >-
      Review guidance names topical DEET and permethrin-treated clothing as the
      main personal-protection measures against tick bites.
📚

References & Deep Research

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: Rickettsia helvetica spotted fever · 2026-09-28T09:33:27Z · View source

Created a new Rickettsia helvetica spotted fever entry with MONDO/NCBI Taxon grounding, Ixodes-associated transmission, conserved spotted-fever-group rickettsial pathophysiology, core febrile and musculoskeletal phenotypes, doxycycline therapy, tick-bite prevention, generated term/reference caches, and OpenScientist deep research.

OpenScientist ▸
Rickettsia helvetica Spotted Fever — Comprehensive Disease Characteristics Report
openscientist-autonomous 27 citations 2026-09-28T02:27:53.551139

Rickettsia helvetica Spotted Fever — Comprehensive Disease Characteristics Report

Disease: Rickettsia helvetica Spotted Fever MONDO ID: MONDO:0000331 (spotted fever group rickettsiosis parent) Category: Infectious Disease (tick-borne bacterial zoonosis) Causative organism: Rickettsia helvetica (NCBI:txid35789), spotted fever group (SFG) Rickettsiaceae

Summary

Rickettsia helvetica spotted fever is an emerging, generally mild tick-borne rickettsiosis caused by the obligate intracellular gram-negative bacterium Rickettsia helvetica, a member of the spotted fever group (SFG) of the genus Rickettsia. It is transmitted principally by the European sheep tick Ixodes ricinus and is the only non-imported rickettsia known to circulate in Scandinavia. The disease is best characterized clinically by an aneruptive (rashless) febrile illness accompanied by headache and myalgia during the warm season — a presentation that distinguishes it from most other SFG rickettsioses, which typically produce a rash and/or an inoculation eschar. A recognized but rare severe end of the spectrum includes lymphocytic meningitis, neuritis (facial palsy/sudden deafness associations), and chronic perimyocarditis linked to sudden cardiac death. Localized skin lesions, eschar, and regional lymphadenopathy (a TIBOLA/SENLAT-like picture) have also been documented at tick-bite sites, broadening the clinical spectrum beyond the classical "rashless fever."

Mechanistically, the organism is inoculated by a feeding tick, replicates within human monocytes/macrophages (an early cellular target), and disseminates to its ultimate target — the vascular endothelium — producing the perivascular and vasculitic lesions seen in skin capillaries and cardiac tissue. In vitro, R. helvetica exhibits actin-based intracellular motility, expresses the surface cell antigen Sca4, invades neurons, and can grow within the host-cell nucleus, features relevant to cell-to-cell spread and central nervous system involvement. Because the disease is purely infectious/environmental in origin, there is no heritable genetic cause, no causal human gene, and no inheritance pattern; sections of the research template dealing with germline genetics, chromosomal abnormalities, and Mendelian inheritance are not applicable.

Diagnosis rests on serology (indirect immunofluorescence assay, IFA, requiring a four-fold IgG titre rise) and molecular detection (PCR/sequencing of rickettsial genes such as 16S rRNA, 17-kDa protein, gltA, ompA, ompB, and sca4), with lesion capillary blood and cerebrospinal fluid outperforming whole blood. Doxycycline is the treatment of choice for patients of all ages, and the prognosis is generally excellent, with the great majority of infections being asymptomatic seroconversions or self-limited flu-like illness. No vaccine exists; prevention relies on tick-bite avoidance and prompt tick removal. An early hypothesis linking R. helvetica to sarcoidosis pathogenesis has been repeatedly refuted.

Key Findings

1. Definition, taxonomy, vector, and clinical triad (F001)

Rickettsia helvetica is an emerging human pathogen within the spotted fever group of rickettsiae, transmitted by Ixodes ricinus, and associated with three recognized human manifestations: aneruptive (rashless) febrile illness, meningitis, and sudden death in chronic perimyocarditis. It holds the distinction of being the only non-imported rickettsia found in Scandinavia, first detected in I. ricinus ticks before any human disease link was established.

"Rickettsia helvetica is an emerging human pathogen, belonging to the spotted fever group (SFG) rickettsiae, associated with generally aneruptive fever, meningitis, and sudden death in chronic perimyocarditis." — PMID: 29664700

"Rickettsia helvetica is the only non-imported rickettsia found in Scandinavia. It was first detected in Ixodes ricinus ticks, but has never been linked to human disease." — PMID: 10513711 (statement predates the perimyocarditis link established in that same landmark paper)

Ontology suggestions: MONDO:0000331 (spotted fever); NCBITaxon:35789 (Rickettsia helvetica); NCBITaxon:34613 (Ixodes ricinus).

2. Typical presentation — mild aneruptive febrile illness (F002)

In a landmark case series of eight patients from France, Italy, and Thailand with serological evidence of infection (Fournier et al. 2004), the disease presented as a mild, warm-season illness with fever, headache, and myalgia but without a cutaneous rash — hence "aneruptive fever." This is a key differentiator from other SFG rickettsioses (e.g., Mediterranean spotted fever, Rocky Mountain spotted fever), which characteristically produce rash and/or eschar.

"The infection presented as a mild disease in the warm season and was associated with fever, headache, and myalgia but not with a cutaneous rash." — PMID: 14766859

"R. helvetica should be suspected in patients with unexplained fever, especially following a bite from an Ixodes sp. tick." — PMID: 14766859

HPO suggestions: Fever (HP:0001945); Headache (HP:0002315); Myalgia (HP:0003326).

3. The refuted sarcoidosis hypothesis (F003)

An initial hypothesis (Nilsson et al.) proposed R. helvetica as an aetiological agent in sarcoidosis. This has not withstood independent scrutiny. Multiple Scandinavian/Danish studies using serology, real-time PCR, and fluorescence in situ hybridization (FISH) on sarcoidosis patient tissues and sera failed to detect Rickettsia and found no serological difference versus controls. In one archival study of sarcoidosis versus control mediastinal lymph node biopsies, no rickettsial DNA was found by PCR/FISH; a serosurvey found antibodies in 1/49 (2%) sarcoidosis patients versus 4/51 (8%) controls (not significant). A subsequent large meta-analysis likewise did not associate R. helvetica with sarcoidosis.

"Our results do not support the hypothesis that Rickettsia is involved in the pathogenesis of sarcoidosis." — PMID: 21284566

"the current study does not support an association between rickettsia and sarcoidosis" — PMID: 15516677

Supporting negative evidence: PMID: 20298335 (2% vs 8%, NS), PMID: 19685374 (prospective, negative), PMID: 21299929 (thesis, negative), PMID: 27894280 (meta-analysis: R. helvetica not associated).

4. Pathogenesis — cellular targets and intracellular mechanisms (F004)

In vitro studies establish the cellular mechanics of infection. R. helvetica survives and propagates in human THP-1 monocytes — an early target after tick inoculation — and induces TNF-α. In mouse NSC-34 neurons it forms short polar actin tails enabling intracellular movement and cell-to-cell spread, expresses Sca4 (which, with vinculin, facilitates passage across the cell membrane), and can invade and grow within the host-cell nucleus. As with other SFG rickettsiae, the ultimate target is the vascular endothelium, producing the perivascular/vasculitic lesions observed in skin capillaries and cardiac tissue.

"Our results show that R. helvetica survives and propagates in the THP-1 cells." — PMID: 33276122

"Short actin tails were shown at the polar end of the bacteria, which makes it likely that they can move intracellularly, and even spread between cells." — PMID: 37085774

"The bacteria were also shown to invade and grow in the cell nucleus of the neuron." — PMID: 37085774

Ontology suggestions: GO:0006928 (movement of cell / actin-based motility); CL:0000576 (monocyte); CL:0000235 (macrophage); CL:0000115 (endothelial cell); CL:0000540 (neuron); UBERON:0001981 (blood vasculature); GO:0005634 (nucleus) as invaded compartment.

5. Epidemiology and vector ecology (F005)

R. helvetica is among the most common tick-borne organisms in European I. ricinus, with prevalences of 4.7–13% in Danish ticks and ~7.7% in Serbian I. ricinus. It frequently co-occurs with Borrelia burgdorferi sensu lato because they share the I. ricinus vector: 25% of B. burgdorferi-positive ticks in the Netherlands were co-infected with rickettsiae, predominantly R. helvetica. Small mammals — especially Apodemus mice — act as reservoirs; R. helvetica was the dominant species (90.9%) among rickettsia-positive German rodents/shrews. Human exposure is often asymptomatic seroconversion or mild self-limiting illness. SFG seroprevalence reached 32% among patients tested for neuroborreliosis and 31.1% among tick-exposed workers versus 13.3% controls (Poland).

"With a prevalence of 4.7-13% in Danish Ixodes ricinus ticks, Rickettsia helvetica is one of the most frequently detected tick-borne organisms in Denmark." — PMID: 29996782

"of all the Borrelia burgdorferi s.l.-positive ticks, 25% were co-infected with rickettsiae" — PMID: 26739030

"Rickettsia helvetica (90.9%) was found as the dominantly occurring species in the four investigated federal states" — PMID: 29398604

Risk factors (from PMID: 27631765): occupational exposure to ticks (p = 0.002), frequency of tick bites (p = 0.02), and male gender (p = 0.005).

6. Treatment — doxycycline is first-line (F006)

As for all SFG rickettsioses, doxycycline is the recommended first-line therapy for R. helvetica infection, for patients of all ages, with early empirical treatment based on clinical suspicion being critical to prevent severe outcomes. In recent tick-bite-associated cases (Serbia, 2025), clinical signs resolved after doxycycline. No vaccine exists.

"Doxycycline is the treatment of choice for patients of all ages; early treatment based on clinical diagnosis is critical to prevent severe outcomes." — PMID: 34526545

"Clinical signs resolved after doxycycline." — PMID: 42520541

NCIT suggestion: Doxycycline (NCIT:C557).

7. Diagnostics — serology plus molecular detection (F007)

Diagnosis uses: (1) IFA with R. helvetica antigen, requiring a four-fold IgG titre rise for confirmation (cut-offs 1/64–1/128; endpoint titres up to 1/320 in a cardiac case); (2) PCR/sequencing of rickettsial genes — 16S rRNA and the 17-kDa outer-membrane protein gene (original 1999 cases), and gltA, ompA, ompB, sca4 for genotyping — performed on skin lesion biopsy, capillary/lesion blood, whole blood, or CSF. Critically, lesion capillary blood outperformed whole blood (which was PCR-negative) in recent cases. Immunohistochemistry/electron microscopy of skin biopsies shows rickettsia-like organisms in the walls of skin capillaries and veins. Serology cannot reliably distinguish species within SFG owing to strong cross-reactivity.

"All patients showed a four-fold increase in antibody titer to the spotted fever rickettsia, R. helvetica, and immunohistochemical examination revealed rickettsia-like organisms in the walls of skin capillaries and veins." — PMID: 15723687

"Rickettsia spp. DNA was detected in capillary blood from both lesions, and sequencing of the PCR amplicons identified R. helvetica, while whole blood was PCR-negative" — PMID: 42520541

"Owing to a known occurrence of immunological cross-reactivites, however, the results must be cautiously interpreted with regard to species of Rickettsia involved" — PMID: 17852905

8. Local skin lesions, eschar, and lymphadenopathy — a broadened spectrum (F008)

Although classically "aneruptive," tick-bite-associated cases show local dermatologic signs: pruritic erythematous lesions, eschar, and non-specific bite-site lesions. An 8-year-old girl developed a pruritic scalp papule/crust with occipital/cervical lymphadenopathy after a Haemaphysalis punctata bite (R. helvetica confirmed by sequencing of lesion and whole-blood PCR), resembling a mild TIBOLA/SENLAT-like localized presentation. This implicates H. punctata as an alternative vector alongside I. ricinus.

"An 8-year-old girl (Case 2) developed a pruritic scalp papule/crust and occipital/cervical lymphadenopathy after an adult female Haemaphysalis punctata attachment" — PMID: 42520541

"Eight patients developed local skin lesions at the site of the tick bite including non-specific lesions, itching sensation at the lesion site, and eschar." — PMID: 36435213

HPO suggestions: Skin ulcer / eschar (HP:0200042); Lymphadenopathy (HP:0002716); Pruritus (HP:0000989).

9. Emerging pathogen status and prognosis (F009)

Review-level evidence places R. helvetica among the emerging European SFG rickettsioses transmitted by I. ricinus (alongside R. monacensis; R. slovaca/raoultii causing TIBOLA; R. conorii causing Mediterranean spotted fever). It is described as a human pathogen "in cases of fever with and without rash and in patients with meningitis and carditis." The great majority of infections are asymptomatic seroconversions or mild, self-limiting flu-like illness with full recovery on doxycycline; severe outcomes (fatal chronic perimyocarditis/sudden cardiac death, meningitis, possible endocarditis) are rare. No confirmed genetic host-susceptibility loci, chromosomal abnormalities, or inheritance patterns apply — the etiology is purely infectious/environmental.

"Rickettsia helvetica has also been involved as a human pathogen in cases of fever with and without rash and in patients with meningitis and carditis." — PMID: 23177355

"Emerging pathogens, including bacteria of the order Rickettsiales (Anaplasma phagocytophilum, 'Candidatus Neoehrlichia mikurensis,' Rickettsia helvetica, and R. monacensis)" — PMID: 25520947

Section-by-Section Report

1. Disease Information

Rickettsia helvetica spotted fever is a tick-borne bacterial zoonosis caused by the obligate intracellular SFG rickettsia R. helvetica. It typically manifests as a mild, self-limiting, often rashless febrile illness, with rare severe cardiac and neurological complications.

Key identifiers: - MONDO: MONDO:0000331 (spotted fever group parent term) - Organism NCBI Taxon: 35789 (Rickettsia helvetica) - OMIM: Not applicable (non-genetic infectious disease) - Orphanet: No dedicated rare-disease entry specific to R. helvetica - ICD-10: A77.8 (Other spotted fevers) / ICD-11: 1C30.Z (Spotted fever, unspecified) - MeSH: Rickettsia helvetica; Spotted Fever Group; Rickettsia Infections

Synonyms: R. helvetica infection; R. helvetica rickettsiosis; aneruptive fever associated with R. helvetica. Historically the organism was designated the "Swiss agent."

Information source: Evidence is derived predominantly from aggregated disease-level resources — case series, serosurveys, tick surveillance studies, and in vitro experiments — rather than large EHR patient cohorts, reflecting the rarity of confirmed symptomatic human cases.

2. Etiology

Causal factor: Purely infectious — the obligate intracellular gram-negative bacterium R. helvetica. There is no genetic or heritable etiology.

Risk factors (environmental/behavioral): Tick exposure is the dominant risk. Occupational exposure to ticks (p = 0.002), frequency of tick bites (p = 0.02), and male gender (p = 0.005) were significant risk factors for SFG seropositivity (PMID: 27631765). Warm-season outdoor activity in endemic European regions increases exposure. No genetic risk/susceptibility loci or protective alleles have been identified. Gene–environment interactions are not applicable.

3. Phenotypes

Phenotype Type Frequency/Severity HPO suggestion
Fever Symptom Common; warm season; mild HP:0001945
Headache Symptom Common HP:0002315
Myalgia Symptom Common HP:0003326
Absence of rash (aneruptive) Distinguishing sign Typical —
Local skin lesion / eschar Clinical sign In tick-bite-associated cases HP:0200042
Regional lymphadenopathy Clinical sign TIBOLA/SENLAT-like cases HP:0002716
Meningitis (lymphocytic) Severe manifestation Rare HP:0100785
Perimyocarditis / sudden cardiac death Severe manifestation Rare, potentially fatal HP:0001657 (pericarditis)
Facial palsy / sudden deafness (association) Neurological Uncommon, association HP:0010628 / HP:0008527

Onset: Adult-onset most common (also pediatric, e.g., the 8-year-old case); acute/subacute onset. Severity: Predominantly mild; rarely severe. Progression: Usually self-limited; chronic perimyocarditis is the exception. QoL impact: Minimal in typical mild disease; severe/fatal only in rare cardiac cases.

4. Genetic/Molecular Information

Not applicable to the human host. R. helvetica spotted fever is an infectious disease with no causal human gene, no pathogenic germline/somatic variants, no modifier genes, no relevant human epigenetic changes, and no chromosomal abnormalities. Molecular characterization pertains to the pathogen genome — genes used for diagnosis/genotyping include 16S rRNA, 17-kDa protein gene, gltA (citrate synthase), ompA, ompB, and sca4 (PMID: 32723640, PMID: 21142961).

5. Environmental Information

Environmental factors: Exposure to questing I. ricinus (and, less commonly, Haemaphysalis punctata) ticks in European woodland, peri-urban, and urban green areas (PMID: 25520947, PMID: 29664700). Lifestyle factors: Outdoor occupation/recreation during warm months. Infectious agent: R. helvetica (NCBITaxon:35789); reservoirs are small mammals, especially Apodemus mice (PMID: 29398604). Co-infection with Borrelia burgdorferi s.l. is common (PMID: 26739030).

6. Mechanism / Pathophysiology

Ordered causal chain (initiating exposure → clinical manifestation):

  1. An infected Ixodes ricinus (or Haemaphysalis punctata) tick attaches and feeds, inoculating R. helvetica into the dermis. (vector demonstrated; inoculation route inferred from SFG biology)
  2. Inoculated bacteria infect and replicate within human monocytes/macrophages at/near the bite site — an early cellular target — and induce TNF-α, initiating a proinflammatory response. (demonstrated in vitro, THP-1 cells, PMID: 33276122)
  3. Intracellular bacteria polymerize host actin into short polar tails, driving intracellular movement and cell-to-cell spread; Sca4 with vinculin enables passage across the cell membrane. (demonstrated in vitro, PMID: 37085774)
  4. Dissemination leads to infection of the vascular endothelium (the ultimate SFG target), resulting in perivascular inflammation and vasculitis in small vessels. (inferred from SFG biology + IHC of skin capillary/vein walls, PMID: 15723687)
  5. Endothelial/vascular injury produces the clinical manifestations:
  6. Branch A (typical): systemic cytokine response results in fever, headache, myalgia (aneruptive febrile illness).
  7. Branch B (cutaneous): local vasculitis results in bite-site skin lesion, eschar, and regional lymphadenopathy.
  8. Branch C (cardiac, rare): chronic vascular/myocardial involvement leads to perimyocarditis and, rarely, sudden cardiac death. (inferred from post-mortem association, PMID: 10513711)
  9. Branch D (neurological, rare): neuronal/CNS invasion (including nuclear growth) leads to meningitis and neuritis. (neuronal invasion demonstrated in vitro, PMID: 37085774; clinical association PMID: 23790098)
 Tick bite ──▶ Monocyte/macrophage infection (+TNF-α)
     │  actin tails, Sca4/vinculin
     ▼
     Cell-to-cell spread ──▶ Endothelial infection ──▶ Vasculitis
                                                │
┌───────────────┬───────────────┬────────────────┬─────┘
▼               ▼               ▼                ▼
   Fever/HA/myalgia  Eschar +         Perimyocarditis   Meningitis /
   (aneruptive)      lymphadenopathy  → sudden death    neuritis
   [typical]         [TIBOLA-like]    [rare, fatal]     [rare]

Cell types (CL): monocyte (CL:0000576), macrophage (CL:0000235), endothelial cell (CL:0000115), neuron (CL:0000540). Biological processes (GO): actin-based movement (GO:0006928), inflammatory response (GO:0006954), TNF production (GO:0032640). Subcellular: host-cell nucleus (GO:0005634) invaded.

7. Anatomical Structures Affected

  • Primary: Vascular endothelium / small blood vessels (UBERON:0001981 blood vasculature). Skin (UBERON:0002097) at bite site.
  • Secondary: Heart — pericardium/myocardium (UBERON:0002348 / UBERON:0001133) in perimyocarditis; meninges (UBERON:0002360) and CNS in neurological cases; lymph nodes (UBERON:0000029) in lymphadenopathy.
  • Body systems: Cardiovascular, integumentary, nervous, lymphatic.
  • Tissue/cell level: Vascular endothelial cells; monocytes/macrophages; neurons (experimental).
  • Lateralization: Local lesions/lymphadenopathy correspond to bite site (may be unilateral/regional); systemic disease is not lateralized.

8. Temporal Development

  • Onset: Acute/subacute, during the warm tick-activity season, days after a tick bite. Affects adults predominantly; pediatric cases occur.
  • Progression: Most cases are self-limited and resolve (spontaneously or rapidly with doxycycline). Rare chronic perimyocarditis represents a progressive/fatal course.
  • Course pattern: Typically monophasic and self-limiting; chronic in the rare cardiac form.
  • Critical period: Early doxycycline (as for SFG rickettsioses generally) is the key window to prevent severe outcomes (PMID: 34526545).

9. Inheritance and Population

  • Inheritance: Not applicable (infectious disease; no heritable component).
  • Epidemiology: Human symptomatic incidence is not well quantified (likely under-recognized). Tick infection prevalence: 4.7–13% (Denmark), ~7.7% (Serbia). SFG seroprevalence: up to 31–32% in exposed groups vs 13% controls. Reservoirs: Apodemus mice.
  • Geographic distribution: Europe-wide (Scandinavia, Denmark, Netherlands, Germany, Serbia, Italy, Hungary, Poland, France), with detections in Asia (I. persulcatus, Japan). Distribution tracks I. ricinus.
  • Sex ratio: Male predominance in seropositivity (occupational exposure-driven).
  • Age distribution: Predominantly working-age adults; pediatric cases documented.

10. Diagnostics

  • Serology: IFA with R. helvetica antigen; four-fold IgG rise confirmatory (cut-offs 1/64–1/128). Limited by SFG cross-reactivity — cannot reliably resolve species.
  • Molecular: PCR + sequencing of 16S rRNA, 17-kDa, gltA, ompA, ompB, sca4. Lesion capillary blood and CSF outperform whole blood.
  • Histology/IHC/EM: Rickettsia-like organisms in walls of skin capillaries and veins.
  • Differential diagnosis: Lyme borreliosis (co-infection common), other SFG rickettsioses (R. monacensis, R. slovaca/TIBOLA, R. conorii/MSF), anaplasmosis, Candidatus Neoehrlichia mikurensis, tick-borne encephalitis, and — where fever + thrombocytopenia — SFTS-like illnesses.
  • Screening: No asymptomatic-population screening; no newborn/carrier screening (non-genetic).

11. Outcome / Prognosis

  • Prognosis is generally excellent. Most infections are asymptomatic seroconversions or mild, self-limiting flu-like illness with full recovery on doxycycline.
  • Mortality: Very rare, confined to chronic perimyocarditis/sudden cardiac death; possible endocarditis role under investigation. (For SFG rickettsioses broadly, delayed doxycycline markedly worsens outcomes — RMSF data show mortality rising from ~4% to ~35% when treatment is delayed beyond day 5 PMID: 34290155; illustrative of the treatment-timing principle, not R. helvetica-specific mortality.)
  • Prognostic factors: Timeliness of doxycycline; presence of cardiac/CNS involvement.

12. Treatment

  • First-line: Doxycycline (NCIT:C557), for patients of all ages; early empirical treatment based on clinical suspicion. Clinical signs resolved after doxycycline in documented cases.
  • Pharmacogenomics / advanced therapeutics / surgery: Not applicable.
  • Supportive care: Antipyretics/analgesics as needed.
  • No vaccine and no combination-therapy requirement for typical disease.

13. Prevention

  • Primary prevention: Tick-bite avoidance (protective clothing, repellents), prompt tick removal, avoiding tick habitat during peak season; no vaccine exists.
  • Public health / environmental: Vector awareness, tick surveillance, education for occupationally exposed groups.
  • Secondary/tertiary: Early recognition and doxycycline to prevent progression; no population screening programs.
  • Genetic counseling: Not applicable.

14. Other Species / Natural Disease

  • Taxonomy of hosts/vectors: Ixodes ricinus (NCBITaxon:34613), Ixodes persulcatus, Haemaphysalis punctata; reservoir small mammals (Apodemus spp.).
  • Natural disease / veterinary relevance: R. helvetica is widespread in ticks feeding on wildlife and companion animals; dogs serve as sentinels — 93.9% SFG-seropositive in a German study, with 66.0% attributable to R. helvetica (PMID: 25889200). Overt natural disease in animals is not well characterized.
  • Zoonotic potential / cross-species susceptibility: Zoonotic (tick-transmitted); "One Health" framing emphasized in recent case reports (PMID: 42520541).

15. Model Organisms

  • In vitro / cellular models: Human THP-1 monocytes (infection/propagation, TNF-α induction; PMID: 33276122); mouse NSC-34 motor-neuron-like cells (actin tails, Sca4 expression, nuclear invasion; PMID: 37085774).
  • Recapitulation: These cellular models reproduce key mechanistic features (monocyte tropism, actin-based motility, neuronal/nuclear invasion) but not the whole-organism vascular/cardiac disease.
  • Limitations: No established, widely used mammalian in vivo (mouse/rat) disease model specific to R. helvetica was identified; endothelial and cardiac pathogenesis remain to be modeled in vivo.

Mechanistic Model / Interpretation

The coherent narrative that emerges is of a low-virulence, endothelium-tropic SFG rickettsia whose typical clinical footprint is deliberately understated: unlike its more aggressive relatives (R. rickettsii, R. conorii), R. helvetica usually causes an aneruptive febrile illness. The in vitro evidence explains both the mildness and the occasional severity. Early replication in monocytes/macrophages with TNF-α induction accounts for the systemic flu-like syndrome, while actin-based motility and Sca4-mediated membrane traversal provide the machinery for dissemination to endothelium — the shared final common pathway of SFG rickettsioses — yielding the vasculitis documented histologically in skin capillaries and, rarely, in cardiac tissue (perimyocarditis). Demonstrated neuronal invasion and intranuclear growth provide a plausible cellular basis for the rare meningitis/neuritis associations. The disease is therefore best conceptualized as a spectrum from asymptomatic seroconversion → mild aneruptive fever (most common) → localized TIBOLA/SENLAT-like eschar + lymphadenopathy → rare severe cardiac or neurological disease, all converging on endothelial infection and vasculitis, and all responsive to timely doxycycline.

Evidence Base

PMID Role Contribution
29664700 Supports F001 Taxonomy (SFG) + clinical triad
10513711 Supports F001 Vector (I. ricinus); perimyocarditis/sudden death
14766859 Supports F002 Aneruptive febrile presentation
21284566 Refutes sarcoidosis link (F003) Archival PCR/FISH negative
15516677 Refutes sarcoidosis link (F003) Serology negative
27894280 Refutes sarcoidosis link (F003) Meta-analysis: not associated
33276122 Supports F004 Monocyte infection/propagation
37085774 Supports F004 Actin tails, Sca4, nuclear invasion
29996782 Supports F005 Tick prevalence (Denmark)
26739030 Supports F005 Borrelia co-infection
29398604 Supports F005 Small-mammal reservoirs
27631765 Supports F005 Risk factors + seroprevalence
34526545 Supports F006 Doxycycline first-line
42520541 Supports F006/F007/F008 Doxycycline response; lesion-blood PCR; pediatric eschar case
15723687 Supports F007 Four-fold titre; IHC of vessel walls
17852905 Supports F007 SFG serological cross-reactivity
36435213 Supports F008 Local lesions/eschar
23177355 Supports F009 European review; clinical spectrum
25520947 Supports F009 Emerging Rickettsiales classification

Limitations and Knowledge Gaps

  • Sparse confirmed human cases. Diagnosis is complicated by SFG serological cross-reactivity, so many "R. helvetica" attributions rest on serology that cannot resolve species; molecular confirmation is available only in a minority of cases.
  • Incidence unknown. True symptomatic human incidence/prevalence is not quantified; most epidemiological data describe tick/animal prevalence and seroprevalence, not disease burden.
  • Causality of severe outcomes. The perimyocarditis/sudden-death and meningitis/neuritis associations are based on case reports and serology; direct causal proof (isolation from affected tissue in life) is limited.
  • No in vivo disease model. Mechanistic insight derives from cell-culture systems; endothelial/cardiac pathogenesis lacks a validated animal model.
  • Treatment evidence extrapolated. Doxycycline efficacy is inferred from SFG-wide guidance and small case reports, not R. helvetica-specific trials.

Proposed Follow-up Experiments / Actions

  1. Standardized molecular case definition. Promote species-specific PCR (gltA/ompA/ompB/sca4) on lesion capillary blood, CSF, and biopsy over serology alone to build a reliable confirmed-case registry.
  2. Prospective clinical cohort. Enroll febrile tick-bitten patients in endemic European regions with paired sera + molecular testing to estimate symptomatic incidence and the true frequency of cardiac/neurological complications.
  3. In vivo model development. Establish an immunocompetent/immunodeficient mouse model to test endothelial tropism and cardiac pathology, closing the gap between cell-culture mechanisms and organ-level disease.
  4. Endothelial and cardiac mechanism studies. Extend the THP-1/NSC-34 work to primary human endothelial and cardiac cells to directly test the vasculitis/perimyocarditis pathway.
  5. Co-infection interaction studies. Given frequent Borrelia co-infection, evaluate whether co-infection alters clinical severity or diagnostic performance.
  6. Definitively close the sarcoidosis question in the literature/knowledge base as refuted, citing the concordant negative serology/PCR/FISH studies and meta-analysis.

Evidence source types: human clinical (case series, serosurveys, registries), in vitro/cellular (THP-1, NSC-34), tick/animal surveillance, and review/meta-analysis. This report synthesizes 9 confirmed findings across 41 reviewed papers over 5 investigation iterations.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.3.0rc3.

Outcome Count
References checked 27
Resolved 27
Unresolved (possible confabulation) 0
Unverifiable 0
Quoted claims checked 21
Quoted claims found in source 21
Quoted claims not found in source 0
References weighed for topical relevance 27
On topic 25
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 28
Resolved 27
Unresolved (possible confabulation) 0
Obsolete 1
Unverifiable 0
Terms whose name was checked 17
Terms named correctly 5
Terms named as a different term 9
Terms whose name is worth a second look 3

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0000331 (3 mentions) - the report calls it "spotted fever group rickettsiosis parent", "spotted fever", "spotted fever group parent term"; MONDO calls it Rickettsia helvetica spotted fever
  • HP:0001945 (2 mentions) - the report calls it "Common; warm season; mild"; HP calls it Fever
  • HP:0002315 (2 mentions) - the report calls it "Common"; HP calls it Headache
  • HP:0003326 (2 mentions) - the report calls it "Common"; HP calls it Myalgia
  • GO:0006928 (2 mentions) - the report calls it "movement of cell / actin-based motility"; GO calls it obsolete movement of cell or subcellular component
  • NCIT:C557 (2 mentions) - the report calls it "Doxycycline", "First-line: Doxycycline"; NCIT calls it Hydroxychloroquine
  • HP:0002716 (2 mentions) - the report calls it "TIBOLA/SENLAT-like cases"; HP calls it Lymphadenopathy
  • HP:0100785 (1 mention) - the report calls it "Rare"; HP calls it Insomnia
  • HP:0001657 (1 mention) - the report calls it "pericarditis"; HP calls it Prolonged QT interval

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • GO:0006928 (obsolete movement of cell or subcellular component) (2 mentions)

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • NCBITaxon:35789 (2 mentions) - the report calls it "Rickettsia helvetica", "R. helvetica"; NCBITaxon calls it Rickettsia helvetica
  • NCBITaxon:34613 (2 mentions) - the report calls it "Ixodes ricinus", "Taxonomy of hosts/vectors: *Ixodes ricinus"; NCBITaxon calls it Ixodes ricinus**
  • UBERON:0001981 (2 mentions) - the report calls it "blood vasculature"; UBERON calls it blood vessel

Terms named inconsistently

The report gives these identifiers more than one name of its own:

  • MONDO:0000331 - called "spotted fever group rickettsiosis parent", "spotted fever", "spotted fever group parent term"
  • NCBITaxon:35789 - called "Rickettsia helvetica", "R. helvetica"
  • NCBITaxon:34613 - called "Ixodes ricinus", "Taxonomy of hosts/vectors:* Ixodes ricinus"
  • NCIT:C557 - called "Doxycycline", "First-line: Doxycycline"